“Concomitant Eruptive Squamous Atypia and Bullous Drug Eruption Associated With Pembrolizumab”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): 2006-10. https://doi.org/10.25251/skin.8.6.17.